Clinical Trial Update: Epivascular Glia Regression and Macular Pigment Restoration After Faricimab in Diabetic Retinopathy

View source ↗

Summary

This clinical trial update describes observed retinal glial changes and macular pigment restoration after treatment with faricimab in diabetic retinopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy

Drugs mentioned

• Faricimab (faricimab)

Snippet

Sponsor: Federico II University | Conditions: Diabetic Retinopathy, DR | Status: COMPLETED